Concepedia

Paige R. Brooks

PR

Statistics

Publications

6

Citations

1.2K

H-Index

6

Active since

1999

Affiliations

Pfizer (United States)(Current)

Paige R. Brooks is an author at Pfizer (United States) specializing in nicotinic receptor pharmacology, pharmacology, and nicotinic acetylcholine receptor agonism.

Publications per year

1999–2006

6

Publications

6

Varenicline:  An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Jotham W. Coe, Paige R. Brooks, Michael G. Vetelino et al. · Journal of Medicinal Chemistry · 2005 · 933 citations · Full text

, , +17

Boron Trichloride/Tetra-<i>n</i>-Butylammonium Iodide:  A Mild, Selective Combination Reagent for the Cleavage of Primary Alkyl Aryl Ethers

Paige R. Brooks, Michael Wirtz, Michael G. Vetelino et al. · The Journal of Organic Chemistry · 1999 · 117 citations

, , +5

3,5-Bicyclic aryl piperidines: A novel class of α4β2 neuronal nicotinic receptor partial agonists for smoking cessation

Jotham W. Coe, Paige R. Brooks, Michael Wirtz et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 73 citations · Full text

, , +14

In pursuit of α4β2 nicotinic receptor partial agonists for smoking cessation: Carbon analogs of (−)-cytisine

Jotham W. Coe, Michael G. Vetelino, Crystal G. Bashore et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 68 citations · Full text

, , +14

Enantioselective Synthesis of Nicotinic Receptor Probe 7,8-Difluoro-1,2,3,4,5,6- hexahydro-1,5-methano-3-benzazocine

Crystal G. Bashore, Michael G. Vetelino, Michael Wirtz et al. · Organic Letters · 2006 · 24 citations

, , +13

1–5 of 6